Projects and Facilities Committee


Executive Director and Chief Executive Officer, Chinachem Group

Mr. Donald CHOI Wun Hing

BFA , BArch , BSc, MA, MBA, Architect AIBC, MRAIC, RIBA, RAIA, FHKIA, HKIUD, PRC Class 1 Registered Architect Qualification, Registered Architect, Authorised Person

Donald has worked globally as architect and developer for over 30 years. He is familiar with both public and private projects and believes in the power of design and architecture to empower society. Clients have included Hong Kong Government, Airport Authority, Mass Transit Railway Corporation, Urban Renewal Authority, Public Works Canada, British Columbia Buildings Corporation, NGOs and the private sector.

He is currently the Chief Executive Officer of Chinachem Group. He was the Managing Director of Nan Fung Development and before Nan Fung, Director of Foster and Partners and the Authorised Person – Architect for the Hong Kong International Airport Passenger Terminal (HKIA Silver Medal Winner) and many infrastructure projects at Chek Lap Kok. The airport was awarded the Top Ten Construction Projects in the World and has won numerous awards including the Best Airport in the World since opening in 1998.

Donald lives in Hong Kong and is active in community services. He is a Global Trustee of the Urban Land Institute, Vice President [Local Affairs] of the Hong Kong Institute of Urban Design, Trustee of Rhode Island School of Design, Chief Curator for Hong Kong Exhibition at the 17th Venice Biennale 2021 and Honorary Advisor of the Hong Kong Workers’ Health Centre. He is also a Building Committee Member of the CUHK Medical Centre, Member of the Committee on Building Information Modelling of Construction Industry Council, the Chairperson of the Board of Construction Innovation and Technology Application Centre, a Board Member of the Hong Kong Green Building Council and the Business Environment Council. He had taught at the University of Hong Kong and was the former Chairman of the Architects Registration Board, HKSAR.


President, Caritas Institute of Higher Education and Caritas Bianchi College of Careers

Dr. Kim MAK Kin Wah


Kim is currently President of Caritas Institute of Higher Education and Caritas Bianchi College of Careers, leading the mission towards establishing St. Francis University.  Kim holds the degrees of Ph.D. and M.Phil. from Cambridge University, MBA from City University London, and Bachelor of Engineering (1st Class Honours) from University of Western Australia.  Kim also holds the professional qualifications of Chartered Engineer, Member of the Institution of Civil Engineers, and Member of the Institute of Marine Engineering, Science & Technology.

Kim won the Director of the Year Awards of the Institute of Directors in two consecutive years.   He has a combination of success in establishing strategies and business models for corporations and NGOs, working with government, legislators and the media, and leading major projects in Europe, Australia, Hong Kong and Mainland China.  

Active in community services, Kim has been awarded the Bronze Bauhinia Star, and is a Justice of Peace.


Permanent Secretary for Innovation and Technology*

Ms. Annie CHOI Suk Han


Ms Annie CHOI assumed the post of the Permanent Secretary for Innovation and Technology of the Government of the Hong Kong Special Administrative Region in July 2019.

Ms CHOI joined the Administrative Service in 1986 and has served in a number of policy bureaux and departments, including the Civil Service Bureau, the Commerce and Economic Development Bureau, the Financial Services and the Treasury Bureau and the Home Affairs Department. She was the Commissioner for Innovation and Technology from August 2015 to July 2019.

Ms CHOI obtained her Bachelor’s and Master’s degrees in Laws as well as Postgraduate Certificate in Laws from the University of Hong Kong. She also did postgraduate studies in Public Administration at Oxford University, UK and Tsinghua University, PRC.


*Appointed on an ex-officio basis

Chairman, Clarksdale Investment Limited

Ms. Cordelia CHUNG

Cordelia Chung is Chairman of Clarksdale, an investment and consultancy company. Ms Chung is also senior consultant at Raymond T.Y. Chan, Victoria Chan & Co, a law firm specialized in commercial law. Prior to it, Ms Chung led corporate strategy for LIXIL Corporation, a global manufacturer in building materials.

Ms Chung spent 24 years with IBM. She was the first Asian female executive to serve on IBM Chairman & CEO's Strategy Team, setting global directions. She held senior leadership positions including Regional General Manager for Southeast Asian countries; General Manager for IBM China/Hong Kong Limited and General Counsel for Asia Pacific.

Ms Chung serves on Hong Kong Government Human Resources Planning Commission, Hong Kong Personal Data (Privacy) Advisory Committee, Hong Kong Government Research Grants Council, Singapore University of Technology and Design, Dalian CPPCC, and Maryknoll School Foundation and IMC. Her past services include Hong Kong Polytechnic University Council, Court of Hong Kong University of Science and Technology, and Singapore Government Economic Strategies Committee.

Associate Professor, School of Biomedical Sciences Li Ka Shing Faculty of Medicine The University of Hong Kong

Dr. Stephanie Ma Kwai Yee

Dr Stephanie Ma obtained her B.Sc. (Cell Biology and Genetics) and M.Sc. (Experimental Medicine) degrees from the University of British Columbia in Vancouver, Canada. She then graduated with a Ph.D. degree from The University of Hong Kong with an outstanding ranking and was awarded the Li Ka Shing Prize for the Best PhD Thesis of that year. Since then, she has been working at The University of Hong Kong where she is currently an Associate Professor and Associate Director (Knowledge Exchange and Global) in the School of Biomedical Sciences at the Li Ka Shing Faculty of Medicine. Dr Ma is also a Principal Investigator at the State Key Laboratory of Liver Research. Dr Ma's research interest is on exploiting stemness as a cancer cell vulnerability. According to the ISI Essential Science Indicator, Dr Ma is currently listed as the top 1% of most cited scholars under the category of 'clinical medicine' and 'all fields'. She is also the recipient of the 2008 Young Scientist Award in Life Sciences from the Hong Kong Institution of Science, the 2012-13 Outstanding Young Researcher Award from HKU, the 2014 Croucher Innovation Award, the 2014 Scientific Research Outstanding Achievement Awards (Second-class Award in Science and Technology Section) from the Higher Education Institution of China, the 2017 University of British Columbia Alumni Builder Award (Canada) as well as the 2018 Ton Duc Thang University Scientific Prize - Rising Star Award (Vietnam). Dr Ma is also elected as a Founding Member of the Hong Kong Young Academy of Sciences in which she currently serves as the Chair of their Outreach Committee.

Deputy Chairman, Sino Group

Mr Daryl NG Win Kong


Mr Daryl Ng Win-kong, JP, Deputy Chairman of Sino Group. 

Mr Ng has founded the Hong Kong Innovation Foundation to support Hong Kong’s growth into an international innovation and technology hub.  It comprises educational initiatives like Go Code and OC STEM Lab, the sandbox platform of Sino Inno Lab to facilitate co-creation, provision of co-working spaces for start-ups as well as proprietary innovations like the award-winning City Air Purification System.

Mr Ng is also a Member of the Global Leadership Council of Columbia University, a Member of the 12thand 13th Beijing Municipal Committees of CPPCC, a Member of the Cyberport Advisory Panel, a Member of the Council of the University of Hong Kong, a Member of the Court of Hong Kong University of Science and Technology, and a Member of the Singapore Management University International Advisory Council.

Mr Ng holds a Bachelor of Arts degree in Economics and a Master of Science degree in Real Estate Development from Columbia University, and an Honorary Doctor of Humane Letters degree from Savannah College of Art and Design.  He is also an Honorary Fellow of the Open University of Hong Kong.

Medical Advisor, Novartis Pharmaceuticals (HK) Ltd.

Mr. Gavin POON Ka Ming

MPH (HK) MPhil (Cantab)

Gavin Poon is currently a Medical Advisor at the Novartis Pharmaceuticals (HK) Ltd.  Gavin grew up in Hong Kong, and has extensive experience in the life science industry from commercial to clinical development and medical affairs.

He is keen about the impact of policy making and translational medicine, and has obtained BSc, MPH (Health Economics, Policy and Management) from the University of Hong Kong and MPhil in Experimental Medicine from the University of Cambridge.

Being a digital enthusiast, Gavin loves to study how disruptive technology change industrial practice.  He also serves as a member in the Committee on Innovation, Technology & Re-industrialisation and the Statistics Advisory Board of the Government.